...

CCO Official Conference Coverage

Shanghai-Hong Kong International Liver Congress 2006

March 25-28, 2006 | Shanghai, China

New Developments in the Management of Chronic Hepatitis B

Track 1 of 2

CME Program Director: George K. K. Lau, MD

Faculty:

Nancy W.Y. Leung, MDAnna S. F. Lok, MDGuang-bi Yao, MD
  • Nancy W.Y. Leung, MD
  • Anna S. F. Lok, MD
  • Guang-bi Yao, MD

Liver Cancer and Liver Transplantation

Track 2 of 2

CME Program Director: George K. K. Lau, MD

Faculty:

Sum P. Lee, MD, PhDJosep M. Llovet, MD
  • Sum P. Lee, MD, PhD
  • Josep M. Llovet, MD

Coverage in Simplified Chinese

Expert Highlights

Listen to the experts quickly summarize the key issues in liver disease highlighted at the conference!

These audio files are in mp3 format. To listen to the audio, simply click "Download Audio." You must be logged onto the clinicaloptions.com site to listen to or download the mp3 files.

 

Sum P. Lee, MD, PhD headshot

Sum P. Lee, MD, describes the role of genomics and proteomics in the future treatment of HCC, and summarizes data on hepatitis E virus infection in high-risk areas of the world. (4 minutes)

Download Audio
Anna S. F. Lok, MD headshot

Anna S.F. Lok, MD, provides a review of the advantages and disadvantages of current and investigational treatment strategies for chronic hepatitis B. (2 minutes)

Download Audio
George K. K. Lau, MD headshot

George K.K. Lau, MD, reviews the importance of scientific interactions among the international treatment community in meeting the challenges of liver disease prevention and treatment. (2 minutes)

Download Audio
Guang-bi Yao, MD headshot

Guang-bi Yao, MD, discusses the current challenges in hepatitis B treatment. (1 minute)

Download Audio

CCO Slideset

Download slides with Conference highlights to use in your own talks!

This slide presentation is in Microsoft PowerPoint format. To view the slides in your browser, simply click the 'CCO Slideset' links. Mac Users: Slides will download to your desktop.  You must be logged into the clinicaloptions.com site to view or save the slides.

Advances in Viral Hepatitis and Liver Disease Management

Download the Slideset


Format: Microsoft PowerPoint (.ppt) | File size: 738 KB | Date posted: 4/19/2006


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.

Capsule Summary:

2-Year Adefovir Treatment Appears Safe, Effective in HBeAg-Positive Chinese Patients Chronically Infected With HBV

Zheng and colleagues demonstrated 2-year safety and efficacy of adefovir in HBeAg-positive Chinese patients with chronic hepatitis B.

CLICK HERE TO KEEP READING

CLICK HERE FOR RELATED CAPSULE SUMMARIES